SCHEMBL19366107

SCHEMBL19366107

Cc1ccc(NCC(C)C)c(O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.53
LMNA P02545 3/20 0.46
TRPA1 O75762 2/20 0.46
CHRM1 P11229 1/20 0.46
SLC6A2 P23975 1/20 0.46
ADRA1A P35348 1/20 0.46
HTR2B P41595 1/20 0.46
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 3/20 0.41
CXCR2 P25025 2/20 0.41
GAA P10253 6/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4972478 0.83 TRPA1 (0.41) IDO1LMNATRPA1CHRM1SLC6A2
SCHEMBL12327881 0.81 SMN1; SMN2 (0.47) IDO1KMT2AMEN1SMN1; SMN2MAPT
SCHEMBL11211267 0.79 CYP3A4 (0.50) IDO1LMNATRPA1CHRM1SLC6A2
SCHEMBL14838625 0.78 IDO1 (0.41) IDO1LMNAKMT2AHTTKDM4E
SCHEMBL10249397 0.78 HDAC6 (0.50) IDO1SLC6A2SMN1; SMN2MAPTGAA
SCHEMBL14515399 0.77 HTT (0.58) IDO1LMNAKMT2AMEN1SMN1; SMN2
SCHEMBL5271027 0.76 KMT2A (0.46) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL6130191 0.75 LMNA (0.50) IDO1LMNATRPA1CHRM1SLC6A2
SCHEMBL4229470 0.75 IDO1 (0.62) IDO1LMNAKMT2AMEN1MAPT
SCHEMBL1341810 0.74 TDP1 (0.43) IDO1SMN1; SMN2MAPTGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751115-B1 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS LILLY CO ELI (US) 2017-09-20 EP disclosed